Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Keloid Volume and Symptoms Reduction Between Intralesional Umbilical-Cord Mesenchymal Stem Cells, Its Conditioned Medium, and Triamcinolone Acetonide Injection as Keloid Therapy: A Randomised Controlled Trial

NCT05887804 is registered in ClinicalTrials.gov with Rumah Sakit Pusat Angkatan Darat Gatot Soebroto as lead sponsor.

NCT NCT05887804
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05887804 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Keloid Volume and Symptoms Reduction Between Intralesional Umbilical-Cord Mesenchymal Stem Cells, Its Conditioned Medium, and Triamcinolone Acetonide Injection as Keloid Therapy: A Randomised Controlled Trial
Lead sponsor
Rumah Sakit Pusat Angkatan Darat Gatot Soebroto
Phase
Phase 4
Overall status
Completed
Start date
October 1, 2021
Completion date
June 9, 2022
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

keloid, stem cell